Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Schroder Global Healthcare Inclusive - Class A - Accumulation (GBP)

Sell:193.60p Buy:193.60p Change: 0.70p (0.36%)
Prices as at 14 November 2019
Sell:193.60p
Buy:193.60p
Change: 0.70p (0.36%)
You can buy or sell holdings in this fund through an ISA, Lifetime ISA, SIPP or Fund & Share Account
Prices as at 14 November 2019
Sell:193.60p
Buy:193.60p
Change: 0.70p (0.36%)
Prices as at 14 November 2019
You can buy or sell holdings in this fund through an ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Our view on this Fund

This fund does not feature on our Wealth 50 list of what we believe are the best funds in each sector. If a fund is not within our Wealth 50 this is not necessarily a recommendation to sell. However, if you are thinking of adding to your investments we believe Wealth 50 funds are superior alternatives. View funds on the Wealth 50 »

Our view on the sector

It's natural for UK investors to focus on funds investing in their home market. But as the world has become more connected, so has the investment landscape. There are lots of funds investing across the globe, and these can be a great way to diversify an investment portfolio. Funds in the global sector can invest anywhere in the world. But they go about this in different ways. They vary in how much they can invest in certain types of companies, sectors, countries, or regions. Some focus on developed markets or large multinational corporations, while others invest more in higher-risk emerging markets or smaller companies. Some target companies with higher-growth expectations and others search for unloved companies with the potential to recover.

Performance Analysis

Performance analysis for this fund is not available.

Investment Philosophy

Investment philosophy for this fund is not available.

Process and Portfolio Construction

Process and portfolio construction for this fund are not available.

question mark Manager Track Record Based on HL Quantitative Research

This information is currently unavailable.

Fund Track Record

14/11/14 to 14/11/15 14/11/15 to 14/11/16 14/11/16 to 14/11/17 14/11/17 to 14/11/18 14/11/18 to 14/11/19
Annual return 4.71% 18.41% 7.26% 13.29% 7.77%

Please remember past performance is not a guide to future returns. Where no data is shown, figures are not available. This information is provided to help you choose your own investments, remember they can fall as well as rise in value so you may not get back the original amount invested.

Information about the fund

Fund manager biography

manager photo
Manager Name: John Bowler
Manager start date: 31 March 2004
Manager located in: London

- Joined Schroders in 2003 - Investment career commenced in 1994 - Currently Global Sector Specialist covering the healthcare sector and manager of the Schroder Medical Discovery Fund, as well as having primary research responsibility for Pan-European pharmaceuticals. Based in London - John joined Schroders from AXA Investment Managers, where he had worked since 1998 in a global healthcare research role. He was voted top buy-side analyst for the pharmaceutical and healthcare sector in the Institutional Investor Pan European Equity survey in 2002 - Before this, John worked at State Street Research & Management from 1997 as a fund manager / analyst - Earlier, John joined Hill Samuel Asset Management in 1994 as a graduate trainee, later becoming a junior fund manager for UK equities - Institute of Investment Management and Research (IIMR) qualified. Member of the CFA Society of the UK (CFA UK) - PhD in Biochemistry & Physiology, University of Manchester. Degree in Biology, University of Manchester

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Benchmark data provided subject to this disclaimer.
You can buy or sell holdings in this fund through an ISA, Lifetime ISA, SIPP or Fund & Share Account